Lupin Limited公司与SteinCares公司合作,在拉丁美洲销售一种与生物相似的眼病药物。 Lupin Limited partners with SteinCares to sell a biosimilar eye disease drug in Latin America.

一家印度制药公司Lupin Limited与SteinCares合作,在拉丁美洲(不包括墨西哥和阿根廷)将一种类似生物的Ranibizumab商业化。 Lupin Limited, an Indian pharmaceutical company, has partnered with SteinCares to commercialize a biosimilar version of ranibizumab in Latin America, excluding Mexico and Argentina. SteinCares将处理监管和商业方面的问题,而Lupin将制造该药物。 SteinCares will handle regulatory and commercial aspects, while Lupin will manufacture the drug. Ranibizumab治疗各种视网膜病症,包括肌肉畸形和糖尿病眼病。 Ranibizumab treats various retinal conditions, including macular degeneration and diabetic eye diseases. Lupin的目标是改善该地区获得高级视网膜护理的机会。 Lupin's goal is to improve access to advanced retinal care in the region.